• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合鼻病毒展示 MPER 表位可引发抗 HIV 中和反应。

Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.

机构信息

Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey, United States of America ; Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey, United States of America.

出版信息

PLoS One. 2013 Sep 6;8(9):e72205. doi: 10.1371/journal.pone.0072205. eCollection 2013.

DOI:10.1371/journal.pone.0072205
PMID:24039745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3765159/
Abstract

BACKGROUND

The development of an effective AIDS vaccine has been a formidable task, but remains a critical necessity. The well conserved membrane-proximal external region (MPER) of the HIV-1 gp41 glycoprotein is one of the crucial targets for AIDS vaccine development, as it has the necessary attribute of being able to elicit antibodies capable of neutralizing diverse isolates of HIV.

METHODOLOGY/PRINCIPLE FINDINGS: Guided by X-ray crystallography, molecular modeling, combinatorial chemistry, and powerful selection techniques, we designed and produced six combinatorial libraries of chimeric human rhinoviruses (HRV) displaying the MPER epitopes corresponding to mAbs 2F5, 4E10, and/or Z13e1, connected to an immunogenic surface loop of HRV via linkers of varying lengths and sequences. Not all libraries led to viable chimeric viruses with the desired sequences, but the combinatorial approach allowed us to examine large numbers of MPER-displaying chimeras. Among the chimeras were five that elicited antibodies capable of significantly neutralizing HIV-1 pseudoviruses from at least three subtypes, in one case leading to neutralization of 10 pseudoviruses from all six subtypes tested.

CONCLUSIONS

Optimization of these chimeras or closely related chimeras could conceivably lead to useful components of an effective AIDS vaccine. While the MPER of HIV may not be immunodominant in natural infection by HIV-1, its presence in a vaccine cocktail could provide critical breadth of protection.

摘要

背景

开发有效的艾滋病疫苗一直是一项艰巨的任务,但仍是一项至关重要的需求。HIV-1 gp41 糖蛋白的高度保守的膜近端外区(MPER)是艾滋病疫苗开发的关键目标之一,因为它具有能够引发能够中和多种 HIV 分离株的抗体的必要属性。

方法/原理发现:受 X 射线晶体学、分子建模、组合化学和强大的选择技术的指导,我们设计并生产了六种嵌合人类鼻病毒(HRV)的组合文库,展示了与 mAb 2F5、4E10 和/或 Z13e1 对应的 MPER 表位,通过不同长度和序列的接头连接到 HRV 的免疫原性表面环上。并非所有文库都能产生具有所需序列的可行嵌合病毒,但组合方法允许我们检查大量展示 MPER 的嵌合体。在这些嵌合体中,有五种能够显著中和来自至少三种亚型的 HIV-1 假病毒的抗体,在一种情况下,导致对所有六种亚型测试的 10 个假病毒的中和。

结论

对这些嵌合体或密切相关的嵌合体进行优化,可能会成为有效艾滋病疫苗的有用成分。虽然 HIV 的 MPER 在 HIV-1 自然感染中可能不是免疫优势,但它在疫苗鸡尾酒中的存在可以提供关键的广泛保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/69f008f35d0e/pone.0072205.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/6ef60a11c414/pone.0072205.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/a55cb7da6e3f/pone.0072205.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/872773478aea/pone.0072205.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/cc6682682dd1/pone.0072205.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/6f5c01f4e585/pone.0072205.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/efbe5593c157/pone.0072205.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/9f5befca99d5/pone.0072205.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/b7a4aaf3045e/pone.0072205.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/69f008f35d0e/pone.0072205.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/6ef60a11c414/pone.0072205.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/a55cb7da6e3f/pone.0072205.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/872773478aea/pone.0072205.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/cc6682682dd1/pone.0072205.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/6f5c01f4e585/pone.0072205.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/efbe5593c157/pone.0072205.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/9f5befca99d5/pone.0072205.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/b7a4aaf3045e/pone.0072205.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89d1/3765159/69f008f35d0e/pone.0072205.g009.jpg

相似文献

1
Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.嵌合鼻病毒展示 MPER 表位可引发抗 HIV 中和反应。
PLoS One. 2013 Sep 6;8(9):e72205. doi: 10.1371/journal.pone.0072205. eCollection 2013.
2
Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.含 gp41 膜近端外区的多种抗原肽模拟物在豚鼠中引发针对人类免疫缺陷病毒 1 的广泛中和抗体。
J Pept Sci. 2013 Aug;19(8):491-8. doi: 10.1002/psc.2526. Epub 2013 Jun 21.
3
Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.HIV-1 CRF02_AG 感染患者中 4E10 样抗体的抗体谱演变和病毒包膜逃逸。
Retrovirology. 2009 Dec 14;6:113. doi: 10.1186/1742-4690-6-113.
4
Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected].基于计算机设计增强 HIV-1 gp41 表位呈递的嵌合鼻病毒的抗原特性 [更正]。
J Mol Biol. 2010 Apr 2;397(3):752-66. doi: 10.1016/j.jmb.2010.01.064. Epub 2010 Feb 4.
5
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.抗1型人类免疫缺陷病毒(HIV-1)抗体2F5和4E10在糖蛋白gp41的膜近端外部区域只需极少关键残基就能中和HIV-1。
J Virol. 2005 Jan;79(2):1252-61. doi: 10.1128/JVI.79.2.1252-1261.2005.
6
Human Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic Mice.呈现HIV-1膜近端外部区域(MPER)4E10表位的人鼻病毒在人细胞间黏附分子-1(ICAM-1)转基因小鼠中引发中和抗体。
Mol Ther. 2015 Oct;23(10):1663-70. doi: 10.1038/mt.2015.107. Epub 2015 Jun 10.
7
Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.牛乳头瘤病毒样颗粒展示了 HIV-1 gp41 膜近端外部区域的保守表位,诱导了黏膜和系统抗体。
Vaccine. 2013 Nov 4;31(46):5422-9. doi: 10.1016/j.vaccine.2013.09.003. Epub 2013 Sep 19.
8
Selection and immune recognition of HIV-1 MPER mimotopes.HIV-1 MPER 模拟表位的选择和免疫识别。
Virology. 2020 Nov;550:99-108. doi: 10.1016/j.virol.2020.06.016. Epub 2020 Sep 19.
9
Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope.从展示HIV-1 gp41 ELDKWA表位的人鼻病毒中引发的对1型人类免疫缺陷病毒(HIV-1)的广泛中和作用。
J Virol. 2009 May;83(10):5087-100. doi: 10.1128/JVI.00184-09. Epub 2009 Mar 11.
10
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.抗V3/聚糖和抗膜近端外部区域(MPER)中和抗体,而非抗V2/聚糖位点抗体,与更强的抗HIV-1中和广度和效力密切相关。
J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11.

引用本文的文献

1
The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.针对 gp41 膜近端外部区域 (MPER) 的 HIV 疫苗的开发:挑战与展望。
Protein Cell. 2018 Jul;9(7):596-615. doi: 10.1007/s13238-018-0534-7. Epub 2018 Apr 17.
2
DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.DNA 疫苗编码鞭毛蛋白可用作佐剂支架,增强 HIV-1 gp41 膜近端外区免疫原性。
Viruses. 2018 Feb 27;10(3):100. doi: 10.3390/v10030100.
3
Live attenuated Salmonella displaying HIV-1 10E8 epitope on fimbriae: systemic and mucosal immune responses in BALB/c mice by mucosal administration.

本文引用的文献

1
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.一种 gp41 特异性人抗体对 HIV-1 的广泛而强效的中和作用。
Nature. 2012 Nov 15;491(7424):406-12. doi: 10.1038/nature11544. Epub 2012 Sep 18.
2
Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.结构导向的 HIV-1 广谱中和抗体 2F5 的改变揭示了其中和功能的新特性。
PLoS Pathog. 2012;8(7):e1002806. doi: 10.1371/journal.ppat.1002806. Epub 2012 Jul 19.
3
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.
黏膜给予带有 HIV-1 10E8 表位纤毛的减毒活沙门氏菌:BALB/c 小鼠的系统和黏膜免疫应答。
Sci Rep. 2016 Jul 14;6:29556. doi: 10.1038/srep29556.
4
Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.通过破坏六螺旋束结构来调节HIV-1 gp41膜近端外部区域的免疫原性特性。
Virology. 2016 Mar;490:17-26. doi: 10.1016/j.virol.2016.01.002. Epub 2016 Jan 21.
5
Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.一种包含暴露的膜近端外部区域的三聚体gp41免疫原的免疫原性特性。
Virology. 2015 Dec;486:187-97. doi: 10.1016/j.virol.2015.09.010. Epub 2015 Oct 9.
6
Human Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic Mice.呈现HIV-1膜近端外部区域(MPER)4E10表位的人鼻病毒在人细胞间黏附分子-1(ICAM-1)转基因小鼠中引发中和抗体。
Mol Ther. 2015 Oct;23(10):1663-70. doi: 10.1038/mt.2015.107. Epub 2015 Jun 10.
7
Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.展示HIV-1包膜膜近端外部区域(MPER)的多聚体支架与gp160 DNA共同免疫时,可诱导产生MPER特异性抗体和交叉中和抗体。
PLoS One. 2014 Dec 16;9(12):e113463. doi: 10.1371/journal.pone.0113463. eCollection 2014.
8
Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.订书钉状 HIV-1 肽重现抗原结构并结合广泛中和抗体。
Nat Struct Mol Biol. 2014 Dec;21(12):1058-67. doi: 10.1038/nsmb.2922. Epub 2014 Nov 24.
9
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.一种融合中间gp41免疫原可引发针对HIV-1的中和抗体。
J Biol Chem. 2014 Oct 24;289(43):29912-26. doi: 10.1074/jbc.M114.569566. Epub 2014 Aug 26.
采用不同缀合物的新型 HIV-1 gp41 表位的 Prime boost 疫苗接种方法可诱导小鼠产生中和抗体,该表位包含膜近端外区。
Vaccine. 2012 Mar 2;30(11):1911-6. doi: 10.1016/j.vaccine.2012.01.026. Epub 2012 Jan 23.
4
Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.设计引发 HIV-1 广谱中和抗体的疫苗的合理性。
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007278. doi: 10.1101/cshperspect.a007278.
5
Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41.诱导恒河猴产生识别 HIV-1 gp41 融合中间构象的抗体。
PLoS One. 2011;6(11):e27824. doi: 10.1371/journal.pone.0027824. Epub 2011 Nov 30.
6
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization.抗体在膜结合的 HIV 片段上的作用对于靶向 GP41 的病毒中和至关重要。
Nat Struct Mol Biol. 2011 Oct 16;18(11):1235-43. doi: 10.1038/nsmb.2154.
7
Broad neutralization coverage of HIV by multiple highly potent antibodies.多种高效价抗体对 HIV 的广泛中和覆盖。
Nature. 2011 Sep 22;477(7365):466-70. doi: 10.1038/nature10373.
8
Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.通过基于 HA/gp41 嵌合蛋白的 DNA 和 VLP 疫苗诱导针对 HIV 包膜蛋白 MPER 的中和抗体。
PLoS One. 2011;6(5):e14813. doi: 10.1371/journal.pone.0014813. Epub 2011 May 19.
9
HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies.HIV-1 gp41 核心带有暴露的膜近端外部区域,诱导广泛的 HIV-1 中和抗体。
PLoS One. 2011 Mar 31;6(3):e18233. doi: 10.1371/journal.pone.0018233.
10
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.免疫接种 HIV-1 gp41 亚单位病毒体诱导粘膜抗体,保护非人类灵长类动物免受阴道 SHIV 挑战。
Immunity. 2011 Feb 25;34(2):269-80. doi: 10.1016/j.immuni.2011.01.015.